These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters. Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002 [TBL] [Abstract][Full Text] [Related]
7. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619 [TBL] [Abstract][Full Text] [Related]
8. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model. Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters. Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037 [TBL] [Abstract][Full Text] [Related]
10. The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine. Xu J; Liu M; Niu X; Hanson J; Jung K; Ru P; Tu H; Jones DM; Vlasova AN; Saif LJ; Wang Q Viruses; 2022 Dec; 15(1):. PubMed ID: 36680135 [TBL] [Abstract][Full Text] [Related]
11. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant. Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579 [TBL] [Abstract][Full Text] [Related]
12. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431 [TBL] [Abstract][Full Text] [Related]
13. Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity. Beitari S; Duque D; Bavananthasivam J; Hewitt M; Sandhu JK; Hadžisejdić I; Tran A Virol J; 2023 Jul; 20(1):167. PubMed ID: 37507719 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters. Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339 [TBL] [Abstract][Full Text] [Related]
15. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model. Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract. Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638 [TBL] [Abstract][Full Text] [Related]
17. Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2. Francis ME; Jansen EB; Yourkowski A; Selim A; Swan CL; MacPhee BK; Thivierge B; Buchanan R; Lavender KJ; Darbellay J; Rogers MB; Lew J; Gerdts V; Falzarano D; Skowronski DM; Sjaarda C; Kelvin AA Nat Commun; 2023 Sep; 14(1):5990. PubMed ID: 37752151 [TBL] [Abstract][Full Text] [Related]
18. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters. Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822 [TBL] [Abstract][Full Text] [Related]
19. Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model. Halfmann PJ; Kuroda M; Armbrust T; Accola M; Valdez R; Kowalski-Dobson T; Rehrauer W; Gordon A; Kawaoka Y Cell Rep; 2022 Feb; 38(7):110394. PubMed ID: 35139368 [TBL] [Abstract][Full Text] [Related]
20. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters. Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]